Clinical Trials Browser

Has results × Ado-Trastuzumab Emtansine × Gastrointestinal × Clear all

NCT01702558 2021-01-22

TRAXHER2

Phase 2 Terminated

182 enrolled 44 charts

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT02318901 2019-10-21

PembroMab

Phase 1/2 Terminated

16 enrolled 6 charts

BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02999672 2019-08-28

KAMELEON

Phase 2 Completed

20 enrolled 14 charts

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

NCT01641939 2017-05-12

A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Phase 2/3 Terminated

415 enrolled 25 charts

Gastrointestinal

Stomach Neoplasms